0
Signin
countryflagUS

18889881171

AAPL 167.04 -0.5714% MSFT 404.33 -1.8235% GOOG 157.46 0.3697% GOOGL 155.9725 0.3232% AMZN 179.17 -1.1639% NVDA 846.71 0.7568% META 501.8 1.544% TSLA 149.9 -3.5703% TSM 132.27 -4.8623% LLY 745.95 -0.642% V 271.36 -0.4877% AVGO 1258.99 -1.8431% JPM 181.25 0.6497% UNH 493.18 2.9625% NVO 122.75 -1.4294% WMT 59.27 -0.637% LVMUY 170.18 -0.3338% XOM 118.47 -0.1349% LVMHF 854.0 -0.4662% MA 454.7 -1.1865%

Clearpoint Neuro Inc

Healthcare US CLPT

5.39USD
-0.14(2.53%)

Last update at 2024-04-18T20:00:00Z

Day Range

5.355.69
LowHigh

52 Week Range

4.0511.00
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -16.43500M -14.41000M -6.78200M -5.53979M -6.16347M
Minority interest - - - - -
Net income -16.53800M -15.32000M -9.10800M -6.50401M -6.16347M
Selling general administrative 9.61M 8.76M 5.27M 4.30M 4.33M
Selling and marketing expenses 9.36M 6.92M 5.38M 4.76M 3.53M
Gross profit 13.53M 11.29M 9.12M 7.38M 4.92M
Reconciled depreciation 0.78M 0.16M 0.55M 0.25M 0.11M
Ebit -16.33200M -13.37400M -6.22000M -4.59368M -5.24740M
Ebitda -15.57700M -12.74500M -4.78500M -4.33406M -5.13797M
Depreciation and amortization 0.76M 0.63M 1.44M 0.26M 0.11M
Non operating income net other -0.02200M -0.06300M 0.88M - -
Operating income -16.33200M -13.37400M -6.22000M -4.59368M -5.24777M
Other operating expenses 36.88M 29.67M 19.05M 15.81M 12.60M
Interest expense 0.08M 0.97M 1.44M 0.96M 0.98M
Tax provision - - - - -
Interest income - - - 0.96M 0.92M
Net interest income -0.08100M -0.97300M -1.44400M -0.95517M -0.98038M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.10M 0.91M 2.33M 0.96M 0.06M
Total revenue 20.55M 16.30M 12.83M 11.22M 7.35M
Total operating expenses 29.86M 24.66M 15.34M 11.98M 10.17M
Cost of revenue 7.02M 5.01M 3.71M 3.83M 2.43M
Total other income expense net -0.10300M -1.03600M -0.56200M -0.94611M 0.06M
Discontinued operations - - - - -
Net income from continuing ops -16.43500M -14.41000M -6.78200M -5.53979M -6.16347M
Net income applicable to common shares -16.43500M -14.41000M -6.78200M -5.54000M -6.16347M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 55.49M 65.58M 29.64M 11.93M 7.86M
Intangible assets 1.03M 0.27M 0.35M - -
Earning assets - - - - -
Other current assets 1.72M 0.51M 0.24M 0.36M 0.21M
Total liab 18.60M 16.79M 27.26M 7.34M 6.35M
Total stockholder equity 36.89M 48.79M 2.38M 4.59M 1.51M
Deferred long term liab 0.39M 0.26M 0.21M - -
Other current liab 4.89M 3.14M 1.94M 1.74M 1.16M
Common stock 0.25M 0.24M 0.17M 0.15M 0.11M
Capital stock 0.25M 0.24M 0.17M 0.15M 0.11M
Retained earnings -150.36700M -133.93200M -119.52200M -112.73962M -107.19959M
Other liab 0.39M 0.26M 0.21M 1.16M 1.00M
Good will - - - - -
Other assets 0.58M 0.64M 3.74M 0.72M 0.82M
Cash 27.61M 54.11M 20.10M 5.70M 3.10M
Cash and equivalents - - - - -
Total current liabilities 6.79M 4.75M 3.23M 4.03M 2.01M
Current deferred revenue 1.07M 0.68M 0.56M 1.21M 0.35M
Net debt -15.62900M -41.82500M 4.14M -3.23295M 0.38M
Short term debt 0.56M 0.51M 0.43M 0.11M -
Short long term debt - - - - -
Short long term debt total 11.99M 12.28M 24.24M 2.46M 3.48M
Other stockholder equity 187.01M 182.48M 121.73M 117.17M 110.32M
Property plant equipment 1.26M 2.78M 3.06M 0.82M 0.38M
Total current assets 51.18M 61.89M 25.46M 10.38M 6.65M
Long term investments - - - - -
Net tangible assets 35.86M 48.52M 2.02M 4.59M 1.51M
Short term investments 9.87M - - - -
Net receivables 2.67M 2.34M 1.88M 1.09M 1.23M
Long term debt 9.89M 9.84M 21.28M 2.07M 3.48M
Inventory 9.30M 4.94M 3.24M 3.24M 2.11M
Accounts payable 0.27M 0.43M 0.30M 0.97M 0.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -1.79421M -1.71815M
Additional paid in capital - - - - -
Common stock total equity 0.25M 0.24M 0.17M 0.15M 0.11M
Preferred stock total equity - - - - -
Retained earnings total equity -150.36700M -133.93200M -119.52200M - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.58M 0.64M 0.65M 0.72M 0.82M
Deferred long term asset charges - - - - -
Non current assets total 4.31M 3.69M 4.18M 1.54M 1.20M
Capital lease obligations 2.09M 2.45M 2.96M 0.39M -
Long term debt total 9.89M 9.84M 21.28M 2.07M 3.48M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -9.59000M -0.16800M -0.48200M -0.16019M -0.06349M
Change to liabilities 1.59M 1.45M -0.89600M 2.03M -0.18954M
Total cashflows from investing activities -10.73600M -0.16800M -0.48200M -0.16000M -0.06349M
Net borrowings - - 22.32M -2.13700M -2.00000M
Total cash from financing activities 0.41M 46.88M 22.69M 5.60M -1.49462M
Change to operating activities -1.76300M -0.76200M -0.95000M -0.23800M -0.03185M
Net income -16.43500M -14.41000M -6.78200M -5.53979M -6.16347M
Change in cash -26.49400M 34.01M 14.40M 2.59M -6.18870M
Begin period cash flow 54.11M 20.10M 5.70M 3.10M 9.29M
End period cash flow 27.61M 54.11M 20.10M 5.70M 3.10M
Total cash from operating activities -16.16700M -12.69700M -7.80800M -2.84951M -4.63059M
Issuance of capital stock 0.00000M 46.78M 0.00000M 7.43M 0.00000M
Depreciation 0.78M 0.69M 0.55M 0.25M 0.11M
Other cashflows from investing activities -0.89300M - -0.44100M - -
Dividends paid - - - - -
Change to inventory -4.42100M -1.71400M -0.02500M -1.02461M 0.12M
Change to account receivables -0.21100M 0.63M -0.79100M 0.14M -0.28448M
Sale purchase of stock 0.48M 0.22M 24.63M 7.82M 0.51M
Other cashflows from financing activities -0.06800M -0.13400M 25.53M 0.31M -76.99462M
Change to netincome 4.01M 2.60M 0.20M 0.80M 1.24M
Capital expenditures 1.15M 0.17M 0.48M 0.16M 0.06M
Change receivables -0.21100M -0.65800M -1.75100M - -
Cash flows other operating -1.24800M -0.59700M -1.32300M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -26.49400M 34.01M 14.40M - -
Change in working capital -4.28900M -1.68400M -2.66600M 0.91M -0.38365M
Stock based compensation 4.13M 2.08M 1.09M 0.80M 1.23M
Other non cash items -0.34600M 0.42M 0.89M 0.73M 0.64M
Free cash flow -17.31300M -12.86500M -8.29000M -3.00970M -4.69408M

Fundamentals

  • Previous Close 5.53
  • Market Cap162.99M
  • Volume79310
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-21.74600M
  • Revenue TTM22.32M
  • Revenue Per Share TTM0.91
  • Gross Profit TTM 13.53M
  • Diluted EPS TTM-0.89

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLPT
Clearpoint Neuro Inc		 -0.14 2.53% 5.39 - - 7.08 6.54 6.60 -6.9966
ABT
Abbott Laboratories		 -0.63 0.59% 105.27 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -8.58 2.55% 327.45 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.11 0.14% 79.19 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.54 0.79% 67.42 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain. It has license and collaboration agreements with Clinical Laserthermia Systems AB, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Clearpoint Neuro Inc

120 S. Sierra Avenue, Solana Beach, CA, United States, 92075

Key Executives

Name Title Year Born
Mr. Joseph Michael Burnett Pres, CEO & Director 1977
Mr. Danilo D'Alessandro Chief Financial Officer 1985
Mr. Mazin Sabra Chief Operating Officer NA
Ms. Ellisa Cholapranee Gen. Counsel & Sec. NA
Ms. Jacqueline Keller VP of Marketing NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).